IMPROVING ONCOLOGY RESEARCH WITH INTEGRATED KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

within the fast evolving field of oncology investigate, precise and successful mutation screening is vital for producing specific therapies. The KRAS companies System plays a pivotal job With this landscape by giving complete answers for KRAS mutation profiling and Evaluation. KRAS mutations, present in about 95% of RAS-related oncogenic alteration